Curium Executive and Leadership Team

Tetiana George, the Co-Founder & Chief Executive Officer at Curium, directs the overarching strategic vision for the organization. By prioritizing investment in cutting-edge nuclear diagnostic technologies, the Co-Founder & Chief Executive Officer ensures the company maintains a competitive edge in the global pharmaceutical market. Tetiana George oversees the alignment of research initiatives with long-term growth objectives, fostering a culture of innovation that directly impacts patient care. This leadership role involves constant collaboration with the Board to secure resources for expanding manufacturing capabilities across international territories. By championing the development of advanced therapies, the Chief Executive Officer drives the mission to provide world-class radiopharmaceutical solutions. Through rigorous oversight of corporate performance, the executive maintains high standards of operational excellence. Ultimately, the Co-Founder & Chief Executive Officer secures the future of the company by navigating complex regulatory landscapes and scaling production to meet rising global demand for specialized medical treatments.

James Portwood, the Chief Operating Officer at Curium, manages the complex supply chain and manufacturing infrastructure required to deliver radiopharmaceutical products worldwide. Overseeing the daily production cycles, the Chief Operating Officer ensures that all facilities adhere to stringent safety and quality protocols. James Portwood coordinates with regional logistics teams to optimize the distribution of time-sensitive medical materials across diverse international markets. This leadership role involves streamlining internal processes to increase efficiency and reduce lead times for critical diagnostic therapies. By integrating advanced manufacturing technologies, the Chief Operating Officer supports the company's goal of scaling production capacity to reach more patients. The executive monitors operational metrics to identify bottlenecks and implements solutions that enhance overall output. Through meticulous management of resources and infrastructure, the Chief Operating Officer maintains the reliability of the global supply chain, ensuring that life-saving treatments reach healthcare providers consistently and effectively.

Khaled El-Chebli, the Senior Director, Commercial Strategy and Chief of Staff at Curium, architects the commercial roadmap and facilitates executive decision-making processes. By analyzing market trends and identifying growth opportunities, the Senior Director, Commercial Strategy and Chief of Staff aligns business development efforts with the company's core mission. Khaled El-Chebli manages cross-functional projects that bridge the gap between research, manufacturing, and market entry. This leadership role involves synthesizing data to inform strategic pivots and ensuring that the executive team remains focused on high-impact initiatives. By overseeing the integration of commercial strategies across regional operations, the executive drives revenue growth and market penetration. The Senior Director, Commercial Strategy and Chief of Staff coordinates internal communications to ensure organizational alignment with corporate objectives. Through the application of analytical rigor and strategic planning, the executive supports the expansion of the company's footprint in the competitive landscape of nuclear diagnostics and therapeutic medicine.

Marla Franz, the Global Chief People Officer at Curium, directs the human capital strategy to attract and retain top-tier talent across the international organization. By fostering a culture of innovation and excellence, the Global Chief People Officer ensures that the workforce remains equipped to handle the complexities of pharmaceutical manufacturing. Marla Franz oversees the development of training programs and performance management systems that support the company's mission of enhancing patient lives. This leadership role involves aligning organizational structure with business goals to maximize productivity and employee engagement. By implementing inclusive policies and professional development initiatives, the executive strengthens the internal foundation necessary for long-term growth. The Global Chief People Officer collaborates with other C-suite leaders to cultivate a high-performance environment that attracts experts in nuclear medicine. Through the strategic management of human resources, the executive ensures that the company maintains the specialized talent required to push boundaries in the development of new radiopharmaceutical therapies.